EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Self-efficacy in patients with neovascular age-related macular degeneration in anti-vascular endothelial growth factor therapy

Anas Adnan El-Cheikh Mahmoud, Noreddin Shekho, Maria Kjøller Pedersen, Lonny Stokholm, Yousif Subhi, Jakob Grauslund, Benjamin Sommer Thinggaard

AJO International · 2026-10 · 3 (3) · 100283

DOI: 10.1016/j.ajoint.2026.100283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AJO International, 2026-10. Verfasst von Anas Adnan El-Cheikh Mahmoud und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Synoptik Foundation, Bayer.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We aimed to characterize general self-efficacy (GSE) and its associated factors in patients with nAMD receiving anti-vascular endothelial growth factor therapy Design Cross-sectional study.

Participants

251 patients with nAMD receiving anti-VEGF therapy at a tax-funded hospital setting in Denmark between May and July 2025.

Methods

Participants completed the General Self-Efficacy Scale and the NEI-VFQ-25, alongside a study-specific demographic questionnaire. Clinical data including best-corrected visual acuity (BCVA) and injection history were obtained from medical records. Multivariable linear regression with bootstrapping was performed to evaluate associations between GSE and demographic, clinical, and vision-related quality of life (VRQoL) measures.

Results

Among 251 participants (59.8% women, median age 80.3 years [IQR 75.8–85.4]), the median GSE score was 33.0 (IQR 29.0–38.0). Higher GSE was associated with better BCVA in the better-seeing eye (β, -0.58 per 0.1 logMAR increment [95% CI -0.91 to -0.26]; P < 0.001) and higher VRQoL (β, 2.10 per 10-point increment [95% CI 1.60 to 2.60]; P < 0.001), with the strongest correlations in domains reflecting autonomy (Dependency ρ=0.53, Role Difficulties ρ=0.48). No associations were found between GSE and treatment duration, injection frequency, or laterality.

Conclusions

Among patients with nAMD in treatment with anti-VEGF, self-efficacy was closely tied to functional autonomy and visual function, but showed no statistically significant association with measures of treatment burden. These findings characterize the psychological profile of patients who successfully maintain long-term therapy, and suggest that functional independence may be a clinically relevant consideration in this population.

Förderung

  • Synoptik Foundation
  • Bayer

Zitieren

APA

Mahmoud, A. A. E., Shekho, N., Pedersen, M. K., Stokholm, L., Subhi, Y., Grauslund, J., & Thinggaard, B. S. (2026). Self-efficacy in patients with neovascular age-related macular degeneration in anti-vascular endothelial growth factor therapy. AJO International, 3(3), 100283. https://doi.org/10.1016/j.ajoint.2026.100283

Vancouver

Mahmoud AAE, Shekho N, Pedersen MK, Stokholm L, Subhi Y, Grauslund J, et al. Self-efficacy in patients with neovascular age-related macular degeneration in anti-vascular endothelial growth factor therapy. AJO International. 2026;3(3):100283. doi:10.1016/j.ajoint.2026.100283

BibTeX
@article{Mahmoud2026,
  author = {Mahmoud, Anas Adnan El-Cheikh and Shekho, Noreddin and Pedersen, Maria Kjøller and Stokholm, Lonny and Subhi, Yousif and Grauslund, Jakob and Thinggaard, Benjamin Sommer},
  title = {Self-efficacy in patients with neovascular age-related macular degeneration in anti-vascular endothelial growth factor therapy},
  journal = {AJO International},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {100283},
  doi = {10.1016/j.ajoint.2026.100283}
}
Kostenlos starten →